Evidence map›Paper›PMID 36365701›Full record

ReviewPolymers2022

Progressive Trends on the Biomedical Applications of Metal Organic Frameworks.

Gaurav Awasthi, Sahil Shivgotra, Shibyendu Nikhar, Subramanian Sundarrajan, Seeram Ramakrishna, Pawan Kumar

Abstract readReview
In one paragraph

Review in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Contrast Agents for Enhanced Bioimaging: A Comprehensive Review.Chembiochem : a European journal of chemical biology · 2026
    Review
  3. The MOF-Microbiome Axis: a New Paradigm for Precision Nanomedicine.Probiotics and antimicrobial proteins · 2026
    Review
  4. Article
  5. Review
  6. Metal-organic frameworks in oral drug delivery.Asian journal of pharmaceutical sciences · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gaurav AwasthiMaterials Application Research Laboratory, Department of Nano Sciences and Materials, Central University of Jammu, Jammu 181143, India.
Sahil ShivgotraMaterials Application Research Laboratory, Department of Nano Sciences and Materials, Central University of Jammu, Jammu 181143, India.
Shibyendu NikharMaterials Application Research Laboratory, Department of Nano Sciences and Materials, Central University of Jammu, Jammu 181143, India.
Subramanian SundarrajanNUS Centre for Nanotechnology and Sustainability, Department of Mechanical Engineering, National University of Singapore, Singapore 11758, Singapore.ORCID 0000-0001-9608-2132
Seeram RamakrishnaNUS Centre for Nanotechnology and Sustainability, Department of Mechanical Engineering, National University of Singapore, Singapore 11758, Singapore.ORCID 0000-0001-8479-8686
Pawan KumarMaterials Application Research Laboratory, Department of Nano Sciences and Materials, Central University of Jammu, Jammu 181143, India.ORCID 0000-0003-0712-8763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel materials have been developed because of technological advancements combined with material research. Metal-organic frameworks (MOF) technology has been investigated for biomedical applications in this line. Nonetheless, as our team has learned from current literature, selecting metal ions/organic linkers, synthesis techniques, water stability/solubility, toxicity, and the possibility of biomolecules/drugs (enzyme, protein, DNA/RNA, and antibodies, among others) tagging/conjugation are the major challenges/factors. These issues/factors have an impact on MOFs' performance in biomedical applications, and they also raise a lot of doubts about its real-time biological utility in the near future. We targeted a comprehensive review on the MOFs for biomedical applications to keep these considerations in mind. The evolution of MOF technology is based on their interesting features such as biological or pharmacological activity, biocompatibility, limited toxicity, and particular host-guest interactions, as well as environmental friendliness. In this paper, we have summarized the state-of-the-art progress pertaining to MOFs' biomedical applications such as biosensing, biomedical, and drug delivery applications in this field that is still very new.

Indexed as

biomedical applicationsbiomoleculesdrugMOF technologytoxicity

Identifiers

PMID36365701
PMCPMC9658682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.